Related Experiment Video
Updated: Jan 11, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Cardiac Damage Staging, Moderate Aortic Stenosis, and the Impact of Aortic Valve Replacement
Evan K Harmon1, Travis Howard1, Larisa G Tereshchenko2
1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Insights
Cardiac damage stage predicts outcomes in moderate aortic stenosis (AS). Damage progresses before aortic valve replacement (AVR) but improves after the procedure.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Outcomes
Background:
- Cardiac damage staging is crucial for severe aortic stenosis (AS) outcomes.
- Its role in moderate AS and the natural history pre- and post-aortic valve replacement (AVR) require further investigation.
Purpose of the Study:
- To assess if cardiac damage stage predicts cardiovascular outcomes in moderate AS.
- To describe the temporal changes in cardiac damage stage following AVR.
Main Methods:
- Retrospective single-center cohort study of 688 patients with moderate AS.
- Stratification by baseline cardiac damage stage.
- Assessment of composite outcomes (all-cause death, HF hospitalization) and AVR timing.
- Evaluation of cardiac damage stage changes over time.
Main Results:
- Higher baseline cardiac damage stages correlated with increased risk of all-cause death and heart failure (HF) hospitalization.
- Patients awaiting AVR experienced a progression of cardiac damage over a median of 3.1 years.
- Cardiac damage showed partial recovery one year after AVR.
Conclusions:
- Cardiac damage stage is a significant predictor of mortality and HF hospitalization in moderate AS.
- Aortic valve replacement can lead to partial recovery of cardiac damage.
- Understanding cardiac damage progression is vital for managing moderate AS patients.
Background:
Cardiac damage stage predicts clinical outcomes in severe aortic stenosis (AS), yet its validation in moderate AS and natural history preaortic valve replacement (AVR) and post-AVR is poorly understood.
Objectives:
This paper sought to: 1) determine whether index cardiac damage stage predicts cardiovascular outcomes in patients with moderate AS; and 2) describe the impact of AVR on cardiac damage stage over time.
Methods:
This retrospective single-center cohort study stratified patients with moderate AS according to index cardiac damage stage. We assessed whether cardiac damage stage predicted a primary composite outcome of all-cause death and heart failure (HF) hospitalization and a secondary outcome of AVR. Changes in stage over time were also assessed.
Results:
Among 688 patients (median follow-up of 3.6 years), baseline cardiac damage stages 0, 1, 2, and 3 to 4 were evident in 25.1%, 24.1%, 41.6%, and 9.2%, respectively. Escalating baseline stage conferred an increased risk of the composite primary endpoint (incidence per 1,000 person years, stage 0: 52 [37, 72]; stage 1: 100 [77, 129], stage 2: 94 [77, 116]; stages 3 to 4: 255 [185, 352]; HR (95% CI); P < 0.001], which was mirrored in survival analyses (all-cause death and HF hospitalization: Plog-rank < 0.001). The net result of awaiting AVR (median time 3.1 years) was an accumulation of cardiac damage, which partially resolved at 1-year.
Conclusions:
Cardiac damage stage is associated with an increasing risk of all-cause mortality and HF hospitalization in patients with moderate AS. The degree of damage accumulates as patients await AVR, which partially recovers post-AVR.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management

